.jpg "Cramer's week ahead: A short week on Wall Street stuffed with earnings reports")
Cramer’s week ahead: A short week on Wall Street stuffed with earnings reports
The stock market will be closed on Thanksgiving Day Thursday and will close at 1 p.m. on Friday. There will, however, be a full slate of earnings reports coming out in the days prior. Cramer gave … Continue reading at cnbc.com
Target praises ‘well-organized’ back rooms in earnings call after reports of overcrowded conditions
“Our teams are telling us that their back rooms have never been so well-organized going into a holiday season,” Target COO John Mulligan said. Continue reading at businessinsider.com
The worst-performing S&P 500 stock is about to report earnings
Macy’s may not be the best stocking stuffer this holiday season. The retailer, which is down nearly 80% from its 2015 peak, is set to report earnings Thursday morning. TradingAnalysis.com founder Todd … Continue reading at cnbc.com
Long Term Investments
How Lowe’s Earnings Report Shows That its Catching Up to Home Depot
Lowe’s (LOW – Get Report) said earnings for the three months ending on November 1 came in at $ 1.41 per share, up 35.6% from the same period last year and firmly ahead of the Street consensus forecast … Continue reading at msn.com
Silgan (SLGN) Up 1.2% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Silgan Holdings (SLGN). Shares have added about 1.2% in that time frame, underperforming the S&P 500. Will the recent positive trend … Continue reading at finance.yahoo.com
Capital: The Story of Long-Term Investment ExcellenceGo inside the elite investment firm with Capital. The Capital Group is one of the world?s largest investment management organizati…
The Permanent Portfolio: Harry Browne’s Long-Term Investment StrategyAn up close look at an investment strategy that can handle today’s uncertain financial environment Market uncertainty cannot be el…
Common Stocks as Long Term Investments2012 Reprint of 1928 Edition. Exact facsimile of the original edition, not reproduced with Optical Recognition Software. Edgar Law…
Long Term Investments
Earnings Season Report: Recap of Q3 2019
Arm yourself with this information emailed to you every trading day. Sign up and get the Earnings Season Report, Earnings Report, Earnings Results Report and Unusual Activity report everyday in your … Continue reading at nasdaq.com
Alexion (ALXN) Up 3.3% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Alexion Pharmaceuticals (ALXN). Shares have added about 3.3% in that time frame, outperforming the S&P 500. Will the recent positive trend … Continue reading at finance.yahoo.com
Home Depot’s Critical Support in Play After Earnings Fall
Shares of Home Depot (HD – Get Report) were taking a tumble on Tuesday, down more than 5% after Wall Street reacts to the company’s third-quarter earnings report. Given the headline results, investors … Continue reading at thestreet.com
Target Reports 4.5% Comp Sales Growth, Remains a Strong Pick
Target (NYSE: TGT) reported very strong third-quarter earnings results that underscore its ability to operate within a shifting retail environment. With solid same-store sales, robust online growth, … Continue reading at nasdaq.com
Lowe's Earnings: LOW Stock Surges 4% on Q3 Results, Outlook
Now for a more in-depth look at the current Lowe's earnings report. Adjusted earnings per share are up 35.58% from $ 1.04 in the third quarter of 2018. Revenue is down slightly from the $ 17.42 billion … Continue reading at investorplace.com
* We all know Gilead Sciences is a favorite of The Motley Fool, and it’s no surprise why. With companies like AbbVie struggling to maintain position in the market after reports to the FDA about liver failure and complications, the other mid-grade companies are vying for that spot.
As time goes on, will these companies put themselves out of business by curing all these hepatitis C patients, or will the future expansion into emerging markets like Japan and Europe help to curb that possibility, allowing for more innovative cures to be generated, in turn expanding profits and market domination?
This podcast was recorded on 11/4/2015.
Imagine owning Amazon.com (up over an insane 4,000% since 2001) when Internet sales rendered big-box retailers obsolete… Now an industry 99% of us use daily is set to implode… And 3 established companies are positioned to take advantage. Click http://bit.ly/1zQXjzy for a stunning presentation.
————————————————————————
Subscribe to The Motley Fool’s YouTube Channel:
http://www.youtube.com/TheMotleyFool
Or, follow our Google+ page:
https://plus.google.com/+MotleyFool/posts
Inside The Motley Fool: Check out our Culture Blog!
http://culture.fool.com
Join our Facebook community:
https://www.facebook.com/themotleyfool
Follow The Motley Fool on Twitter:
Tweets by themotleyfool
Long Term Investments
Great Review, 99% of people in developing countries cant afford $1000 per pill even in developed countries its tough. Not sure if they shall drop the price when the R&D is paid for and then go for more volume….Not sure I will invest I do need some medical stocks though
View Comment